| Identification | Back Directory | [Name]
RTA dh404 | [CAS]
1191265-33-4 | [Synonyms]
CPD3619
RTA dh404
CDDO-dhTFEA (RTA dh404)
Olean-1-en-28-amide, 2-cyano-3,12-dioxo-N-(2,2,2-trifluoroethyl)-
RTA dh 404,Nuclear factor-κB,Inhibitor,RTA dh-404,CDDOdhTFEA,Keap1-Nrf2,RTA dh404,Nuclear factor-kappaB,CDDO dhTFEA,CDDO-dhTFEA,inhibit,NF-κB
(4aS,6aR,6bR,8aR,12aR,12bR,14aR,14bS)-11-cyano-2,2,6a,6b,9,9,12a-heptamethyl-10,14-dioxo-N-(2,2,2-trifluoroethyl)-1,3,4,5,6,6a,6b,7,8,8a,9,10,12a,12b,13,14,14a,14b-octadecahydropicene-4a(2H)-carboxamide | [Molecular Formula]
C33H45F3N2O3 | [MDL Number]
MFCD32201037 | [MOL File]
1191265-33-4.mol | [Molecular Weight]
574.72 |
| Chemical Properties | Back Directory | [Boiling point ]
645.6±55.0 °C(Predicted) | [density ]
1.20±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: 260 mg/mL (452.39 mM) | [form ]
Solid | [pka]
13.76±0.70(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Description]
CDDO-dhTFEA (RTA dh404) is a synthetic oleanane triterpenoid compound which potently activates Nrf2 and inhibits the pro-inflammatory transcription factor NF-κB[1]. CDDO-dhTFEA restores hypertension (MAP), increases Nrf2 and expression of its target genes, attenuates activation of NF-κB and transforming growth factor-β pathways, and reduces glomerulosclerosis, interstitial fibrosis and inflammation in the chronic kidney disease (CKD) rats[2].
NF-κB Nrf2
| [Uses]
CDDO-dhTFEA (RTA dh404) is a synthetic oleanane triterpenoid compound which potently activates Nrf2 and inhibits the pro-inflammatory transcription factor NF-κB[1]. CDDO-dhTFEA restores hypertension (MAP), increases Nrf2 and expression of its target genes, attenuates activation of NF-κB and transforming growth factor-β pathways, and reduces glomerulosclerosis, interstitial fibrosis and inflammation in the chronic kidney disease (CKD) rats[2]. | [IC 50]
Nrf2; NF-κB | [References]
[1]. Aminzadeh MA, et al. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores endothelial function impaired by reduced Nrf2 activity in chronic kidney disease. Redox Biol. 2013 Oct 31;1:527-31.
[2]. Aminzadeh MA, et al. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease. Xenobiotica. 2014 Jun;44(6):570-8. |
|
|